Abstract Background The regulatory cyclin, Cyclin T1 (CycT1), is a host factor essential for HIV-1 replication in CD4 T cells and macrophages. The importance of CycT1 and the Positive Transcription Elongation Factor b (P-TEFb) complex for HIV replication is well-established, but regulation of CycT1 expression and protein levels during HIV replication and latency establishment in CD4 T cells is less characterized. Methods To better define the regulation of CycT1 levels during HIV replication in CD4 T cells, multiparameter flow cytometry was utilized to study the interaction between HIV replication (intracellular p24) and CycT1 of human peripheral blood memory CD4 T cells infected with HIV in vitro. CycT1 was further examined in CD4 T cells o...
Western blot measurement of CycT1 and validation of CycT1 flow cytometric antibody in human memory C...
HIV integrates into the host genome, creating a viral reservoir of latently infected cells that pers...
Highly active antiretroviral therapy (HAART) in individuals infected with HIV-1 often lowers plasma ...
HIV-1 is dependent upon cellular co-factors to mediate its replication cycle in CD4(+) T cells and m...
Generation of p24/CycT1 cells during HIV replication in modestly stimulated memory CD4 T cells. Memo...
In order to eradicate HIV-1 infection the virus needs to be specifically eliminated from latently in...
A major barrier to curing HIV-1 is the long-lived latent reservoir that supports re-emergence of HIV...
Abstract Background P-TEFb, a general RNA polymerase II elongation factor, is composed of CDK9 (cycl...
Background: A major question when attempting to eradicate and treat HIV-1 infection is how to reacti...
© 2011 Wolters Kluwer Health | Lippincott Williams & WilkinsObjective: The dynamics of CD4+ regulato...
The use of antiretroviral therapy in HIV type 1 (HIV-1)–infected patients does not lead to virus era...
Background: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...
Cyclin T1 expression in small and large memory CD4 T cells during T cell activation. Human CD4+CD45R...
BACKGROUND: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...
Regulatory T cells (Treg) are a subpopulation of CD4 T cells characterized by the suppressive activ...
Western blot measurement of CycT1 and validation of CycT1 flow cytometric antibody in human memory C...
HIV integrates into the host genome, creating a viral reservoir of latently infected cells that pers...
Highly active antiretroviral therapy (HAART) in individuals infected with HIV-1 often lowers plasma ...
HIV-1 is dependent upon cellular co-factors to mediate its replication cycle in CD4(+) T cells and m...
Generation of p24/CycT1 cells during HIV replication in modestly stimulated memory CD4 T cells. Memo...
In order to eradicate HIV-1 infection the virus needs to be specifically eliminated from latently in...
A major barrier to curing HIV-1 is the long-lived latent reservoir that supports re-emergence of HIV...
Abstract Background P-TEFb, a general RNA polymerase II elongation factor, is composed of CDK9 (cycl...
Background: A major question when attempting to eradicate and treat HIV-1 infection is how to reacti...
© 2011 Wolters Kluwer Health | Lippincott Williams & WilkinsObjective: The dynamics of CD4+ regulato...
The use of antiretroviral therapy in HIV type 1 (HIV-1)–infected patients does not lead to virus era...
Background: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...
Cyclin T1 expression in small and large memory CD4 T cells during T cell activation. Human CD4+CD45R...
BACKGROUND: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...
Regulatory T cells (Treg) are a subpopulation of CD4 T cells characterized by the suppressive activ...
Western blot measurement of CycT1 and validation of CycT1 flow cytometric antibody in human memory C...
HIV integrates into the host genome, creating a viral reservoir of latently infected cells that pers...
Highly active antiretroviral therapy (HAART) in individuals infected with HIV-1 often lowers plasma ...